Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate CareDx Inc before investing.
In this article, we go over a few key elements for understanding CareDx Inc’s stock price such as:
- CareDx Inc’s current stock price and volume
- Why CareDx Inc’s stock price changed recently
- Upgrades and downgrades for CDNA from analysts
- CDNA’s stock price momentum as measured by its relative strength
About CareDx Inc
(CDNA)
Before we jump into CareDx Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Company’s product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. It develops and provides diagnostic surveillance testing services for various transplant recipients.
Want to learn more about CareDx Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about CareDx Inc.
CareDx Inc’s Stock Price as of Market Close
As of September 30, 2024, 4:00 PM, CST, CareDx Inc’s stock price was $31.23.
CareDx Inc is up 5.13% from its previous closing price of $29.70.
During the last market session, CareDx Inc’s stock traded between $29.50 and $30.32. Currently, there are 52.20 million shares of CareDx Inc stock available for purchase.
Unfortunately, CareDx Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.
CareDx Inc Stock Price History
CareDx Inc’s
(CDNA) price is currently up 1.61% so far this month.
During the month of September, CareDx Inc’s stock price has reached a high of $31.75 and a low of $26.18.
Over the last year, CareDx Inc has hit prices as high as $34.84 and as low as $4.80. Year to date, CareDx Inc’s stock is up 173.66%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused CareDx Inc Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 27, 2024, there were 0 analysts who downgraded CareDx Inc’s stock and 5 analysts who upgraded over the last month.
Additionally, you'll want to evaluate CareDx Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on CareDx Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
CareDx Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about CareDx Inc
(CDNA) by visiting AAII Stock Evaluator.
Relative Price Strength of CareDx Inc
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of September 27, 2024, CareDx Inc has a weighted four-quarter relative price strength of 49.79%, which translates to a Momentum Score of 98 and is considered to be Very Strong.
Want to learn more about how CareDx Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
CareDx Inc Stock Price: Bottom Line
As of September 30, 2024, CareDx Inc’s stock price is $31.23, which is up 5.13% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like CareDx Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
Screen: 23.7%
Annual Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.